Jordi Espadaler Mazo, PhD
Jordi Espadaler Mazo, PhD
Director of Innovation
Kaneka Probiotics / AB-Biotics

Jordi has a PhD in Molecular Biology by the Autonomous University of Barcelona (Spain) with recurrent collaborations with UCSF (US) and completed an open executive education program at IESE business school (Spain). His research career is currently focused on probiotics and the human microbiome. He is Director of Innovation and Chief Scientific Officer at Kaneka Probiotics / AB-Biotics, where his work encompasses management of both lab research and clinical trials. He is also co-founder of Ability Pharmaceuticals, a biotech startup developing an oncology drug (currently in phase II).